TA
BSX icon

Tamarack Advisers’s Boston Scientific BSX Stock Holding History

Tamarack Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,000
Closed -$258K – 49
2021
Q2 		$258K Buy
2,000
+1,000
+100% +$42.1K 0.07% 44
2021
Q1 		$120K Buy
+1,000
New +$37.8K 0.02% 62

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Tamarack Advisers's BSX Position: Q2 2017 in Review

Tamarack Advisers sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 200,000 shares — an estimated $5.31M sold.

Tamarack Advisers first reported a position in BSX in Q4 2016 and held it in 2 quarters. The position peaked at $4.97M in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Tamarack Advisers reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
  • Tamarack Advisers sold 200,000 Boston Scientific shares in Q2 2017, an estimated $5.31M.
  • Tamarack Advisers first reported a position in Boston Scientific in Q4 2016 and held it in 2 quarters.
  • Tamarack Advisers's Boston Scientific position peaked at $4.97M in Q1 2017.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Tamarack Advisers's 13F filing for Q2 2017, filed 8 Aug 2017.